Hypomania after augmenting venlafaxine and olanzapine with sarcosine in a patient with schizophrenia: a case study

Glutamate is the main excitatory neurotransmitter in the central nervous system. Dysfunction of the glutamatergic system plays an important and well-established role in the pathogenesis of schizophrenia. Agents with glutamatergic properties such as N-methyl-D-aspartate receptor coagonists (ie, glyci...

Descripción completa

Detalles Bibliográficos
Autores principales: Strzelecki, Dominik, Szyburska, Justyna, Kotlicka-Antczak, Magdalena, Kałużyńska, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356443/
https://www.ncbi.nlm.nih.gov/pubmed/25784808
http://dx.doi.org/10.2147/NDT.S75734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356443/
https://www.ncbi.nlm.nih.gov/pubmed/25784808
http://dx.doi.org/10.2147/NDT.S75734

Ejemplares similares